​

Funding Round

Series A - Protego Biopharma

Series A - Protego Biopharma

Investment Firm

Overview

Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy.

Announced Date

Oct 19, 2021

Closed on Date

Nov 17, 2021

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Lightspeed Venture Partners

Lightspeed Venture Partners

Lightspeed Venture Partners is a early_stage_venture and late_stage_venture and seed firm.

MPM Capital

MPM Capital

MPM Capital is a early_stage_venture and late_stage_venture and private_equity and seed firm.

Participant Investors

2

Investor Name
Participant InvestorMPM Capital
Participant InvestorLightspeed Venture Partners

Round Details and Background

Protego Biopharma raised $51047342 on 2021-10-19 in Series A

Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 19, 2021
Series A - Protego Biopharma
3-51.0M

Recent Activity

There is no recent news or activity for this profile.